Clinical Trial Update: Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers [Phase 3]

View source ↗

Summary

Phase 3 trial update on yellow fever vaccine administered with tetravalent dengue vaccine in healthy toddlers; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Hemorrhagic Fever
• Yellow Fever

Drugs mentioned

• Yellow Fever vaccine (live attenuated, tetravalent dengue vaccine co-administered)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue, Dengue Hemorrhagic Fever | Phase 3 | Status: COMPLETED | Results posted: 2019-07-29